# Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells（hAECs）

> **NCT03031509** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Nonunion Fracture

## Interventions

- **BIOLOGICAL:** Human Amniotic Epithelial Cells
- **PROCEDURE:** debridement

## Key facts

- **NCT ID:** NCT03031509
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12
- **Primary completion:** 2018-03
- **Final completion:** 2020-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2017-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03031509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03031509, "Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells（hAECs）". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03031509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
